Pharmaceutical Products
With a market exceeding SAR 30 billion, Saudi Arabia targets 40% localization. We support your entry into API production, biosimilars, and advanced drug formulation for the MENA & OIC markets.
Vision 2030 Strategic Objectives
Localization Goal
Aiming for 40% domestic production of the pharmaceutical market by 2030.
Export Hub
Serving the SAR 400B+ regional market including MENA and OIC countries.
Advanced R&D
Fostering clinical trials and biotech research for innovative drug development.
Key Investment Categories
Generics & Formulations
Mass-market generics and advanced pharmaceutical formulations.
Biotech & Biosimilars
Biological medicines and cutting-edge biotechnology products.
API Production
Active Pharmaceutical Ingredients and intermediate chemical synthesis.
Contract Manufacturing
CDMO services, secondary packaging, and outsourcing solutions.
SFDA & GMP Compliance
TAFE JD provides end-to-end support for drug registration, Bioequivalence studies coordination, and WHO prequalification guidance.
Lead Pharma Innovation in the Region
Establish your pharmaceutical facility with comprehensive support for licensing, MODON cluster allocation, and NUPCO tender access.
English 
Arabic